Breaking News, Promotions & Moves

Halix Names New CEO

Dr. Lutz Hilbrich brings over 20 years of experience in the biotechnology and pharmaceutical sectors.

Author Image

By: Charlie Sternberg

Associate Editor

Halix B.V., a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of complex therapeutic antibodies (proteins) and viral products, has appointed Dr. Lutz Hilbrich as its new Chief Executive Officer (CEO), effective immediately.   With over 20 years in the biotechnology and pharmaceutical sectors, Hilbrich brings extensive experience in strategic leadership, operational excellence, and innovation in biopharmaceutical development and manuf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters